Brief: Symetryx Corp Reports 13.8% Stake In Neubase Therapeutics As Of August 22

NeuBase Therapeutics

31/08/2023 17:03

Aug 31 (Reuters) - 
  
    * SYMETRYX CORP REPORTS 13.8% STAKE IN NEUBASE THERAPEUTICS INC AS OF AUGUST 22 - SEC FILING
    * SYMETRYX CORP - INTEND TO PURCHASE ADDITIONAL SHARES OF COMMON STOCK OF NEUBASE
THERAPEUTICS
    * SYMETRYX CORP - AWARE THAT NEUBASE THERAPEUTICS' EXECUTIVE MANAGEMENT ARE CONSIDERING
POTENTIAL
MERGERS
    * SYMETRYX CORP - WILL CONSIDER MERITS OF ANY MERGER, LIQUIDATION, OR OTHER EXTRAORDINARY
BUSINESS
TRANSACTION BEING PROPOSED BY BOARD OF OF NEUBASE
    * SYMETRYX CORP -  INTEND TO DISCUSS WITH EXECUTIVE MANAGEMENT OF NEUBASE ADDING
REPRESENTATIVE OF
REPORTING PERSONS TO BOARD OF NEUBASE

Source text - https://bityl.co/Koz5
Further company coverage:  NBSE.O 

 ((Reuters.Briefs@thomsonreuters.com;))